A detailed history of Clear Rock Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clear Rock Advisors, LLC holds 22,703 shares of ABT stock, worth $2.59 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
22,703
Previous 21,121 7.49%
Holding current value
$2.59 Million
Previous $2.4 Billion 1.73%
% of portfolio
1.01%
Previous 1.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 03, 2024

BUY
$100.73 - $112.44 $159,354 - $177,880
1,582 Added 7.49%
22,703 $2.36 Billion
Q1 2024

Jun 07, 2024

BUY
$109.52 - $120.96 $46,984 - $51,891
429 Added 2.07%
21,121 $2.4 Billion
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $1.87 Million - $2.28 Million
20,692 New
20,692 $2.31 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clear Rock Advisors, LLC Portfolio

Follow Clear Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Rock Advisors, LLC with notifications on news.